{"id":"https://openalex.org/W1982925579","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3354","title":"Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent","display_name":"Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent","publication_year":2013,"publication_date":"2013-02-13","ids":{"openalex":"https://openalex.org/W1982925579","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3354","mag":"1982925579","pmid":"https://pubmed.ncbi.nlm.nih.gov/23406775"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.ccr-12-3354","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3354","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-3354","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3618554","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033416022","display_name":"Emilia Modolo Pinto","orcid":"https://orcid.org/0000-0001-5567-000X","observed_orcids":["https://orcid.org/0000-0001-5567-000X"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emilia M. Pinto","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066877678","display_name":"Christopher L. Morton","orcid":"https://orcid.org/0000-0002-4027-7050","observed_orcids":["https://orcid.org/0000-0002-4027-7050"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christopher Morton","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053318111","display_name":"Carlos Rodriguez Galindo","orcid":"https://orcid.org/0000-0002-2360-8946","observed_orcids":["https://orcid.org/0000-0002-2360-8946"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Carlos Rodriguez-Galindo","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110197815","display_name":"Lisa M. McGregor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lisa McGregor","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063456712","display_name":"Andrew M. Davidoff","orcid":"https://orcid.org/0000-0001-7900-2794","observed_orcids":["https://orcid.org/0000-0001-7900-2794"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andrew M. Davidoff","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034062719","display_name":"Kimberly Mercer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly Mercer","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035871571","display_name":"Larisa V. Debelenko","orcid":"https://orcid.org/0000-0002-9443-5181","observed_orcids":["https://orcid.org/0000-0002-9443-5181"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larisa V. Debelenko","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048193615","display_name":"Catherine A. Billups","orcid":"https://orcid.org/0000-0003-2819-4946","observed_orcids":["https://orcid.org/0000-0003-2819-4946"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Catherine Billups","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086250633","display_name":"Raul Correa Ribeiro","orcid":"https://orcid.org/0000-0002-9956-5647","observed_orcids":["https://orcid.org/0000-0002-9956-5647"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raul C. Ribeiro","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5030630722","display_name":"Gerard P. Zambetti","orcid":"https://orcid.org/0000-0002-0929-5007","observed_orcids":["https://orcid.org/0000-0002-0929-5007"]},"institutions":[{"id":"https://openalex.org/I1288882113","display_name":"Boston Children's Hospital","ror":"https://ror.org/00dvg7y05","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1288882113"]},{"id":"https://openalex.org/I1313298211","display_name":"St. Jude Children's Research Hospital","ror":"https://ror.org/02r3e0967","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1313298211","https://openalex.org/I2802152183"]},{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Gerard P. Zambetti","raw_affiliation_strings":["Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Authors' Affiliations:\u20081International Outreach Program; Departments of 2Biochemistry, 3Surgery, 4Oncology, 5Pathology, and 6Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee; and 7Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"]},{"raw_affiliation_string":"Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, Massachusetts","institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5030630722"],"corresponding_institution_ids":["https://openalex.org/I1288882113","https://openalex.org/I1313298211","https://openalex.org/I4210117453"],"apc_list":null,"apc_paid":null,"fwci":2.9906,"has_fulltext":false,"cited_by_count":33,"citation_normalized_percentile":{"value":0.90197727,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"19","issue":"7","first_page":"1740","last_page":"1747"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11054","display_name":"Adrenal and Paraganglionic Tumors","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11054","display_name":"Adrenal and Paraganglionic Tumors","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10253","display_name":"Sarcoma Diagnosis and Treatment","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-adrenocortical-carcinoma","display_name":"pediatric adrenocortical carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/xenograft-models","display_name":"xenograft models","score":0.921999990940094},{"id":"https://openalex.org/keywords/topotecan","display_name":"topotecan","score":0.9919999837875366},{"id":"https://openalex.org/keywords/tp53-mutation","display_name":"TP53 mutation","score":0.9390000104904175},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.746999979019165},{"id":"https://openalex.org/keywords/chemosensitivity","display_name":"chemosensitivity","score":0.7059999704360962},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.6970000267028809},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.996999979019165},{"id":"https://openalex.org/keywords/loss-of-heterozygosity","display_name":"loss of heterozygosity","score":0.8690000176429749}],"concepts":[{"id":"https://openalex.org/C2781209748","wikidata":"https://www.wikidata.org/wiki/Q419953","display_name":"Topotecan","level":3,"score":0.931320071220398},{"id":"https://openalex.org/C2781399356","wikidata":"https://www.wikidata.org/wiki/Q918285","display_name":"Adrenocortical carcinoma","level":2,"score":0.7481074333190918},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7088040113449097},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6412222981452942},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.544481635093689},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.4554566442966461},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.4542478024959564},{"id":"https://openalex.org/C2993561819","wikidata":"https://www.wikidata.org/wiki/Q5097977","display_name":"Pediatric cancer","level":3,"score":0.4387736916542053},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.4170771837234497},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4060700535774231},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37858879566192627},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.35860198736190796},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3574065566062927},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.33877259492874146},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3259637951850891}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000306","descriptor_name":"Adrenal Cortex Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012008","descriptor_name":"Recurrence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D018268","descriptor_name":"Adrenocortical Carcinoma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019772","descriptor_name":"Topotecan","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D047368","descriptor_name":"Tumor Burden","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D059004","descriptor_name":"Topoisomerase I Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1078-0432.ccr-12-3354","doi":"https://doi.org/10.1158/1078-0432.ccr-12-3354","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1078-0432.ccr-12-3354","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},{"id":"pmid:23406775","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23406775","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical cancer research : an official journal of the American Association for Cancer Research","raw_type":"Journal Article"},{"id":"pmh:oai:europepmc.org:2948848","doi":null,"is_oa":false,"landing_page_url":"http://europepmc.org/articles/PMC3618554","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:3618554","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3618554","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:3618554","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3618554","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Clin Cancer Res","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8299999833106995}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3324934085","display_name":null,"funder_award_id":"CA-023099","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G4766096375","display_name":null,"funder_award_id":"CA021765","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G5145123177","display_name":"Studies of Childhood Solid Tumors","funder_award_id":"P01CA023099","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G9000904664","display_name":"Cancer Center Support Grant (CCSG)","funder_award_id":"P30CA021765","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W31339246","https://openalex.org/W156464271","https://openalex.org/W1571073982","https://openalex.org/W1876202993","https://openalex.org/W1883602322","https://openalex.org/W1935226228","https://openalex.org/W1966384938","https://openalex.org/W1967352082","https://openalex.org/W2000464147","https://openalex.org/W2002793570","https://openalex.org/W2005542290","https://openalex.org/W2007872355","https://openalex.org/W2013170178","https://openalex.org/W2040572070","https://openalex.org/W2051475775","https://openalex.org/W2057860687","https://openalex.org/W2059773232","https://openalex.org/W2060610536","https://openalex.org/W2073340701","https://openalex.org/W2091480567","https://openalex.org/W2094505069","https://openalex.org/W2096859456","https://openalex.org/W2104248574","https://openalex.org/W2105268776","https://openalex.org/W2105447817","https://openalex.org/W2106396959","https://openalex.org/W2114819486","https://openalex.org/W2133220642","https://openalex.org/W2136391811","https://openalex.org/W2145954121","https://openalex.org/W2296141719","https://openalex.org/W2416208430","https://openalex.org/W2430030498","https://openalex.org/W3141275090","https://openalex.org/W4250495686","https://openalex.org/W6715877719"],"related_works":["https://openalex.org/W2398512541","https://openalex.org/W1555002034","https://openalex.org/W2358630441","https://openalex.org/W2040726906","https://openalex.org/W2015170463","https://openalex.org/W81565288","https://openalex.org/W4361911273","https://openalex.org/W4361911226","https://openalex.org/W2045359153","https://openalex.org/W2810643938"],"abstract_inverted_index":{"PURPOSE:":[0],"Pediatric":[1],"adrenocortical":[2],"carcinoma":[3],"(ACC)":[4],"is":[5],"a":[6,84,95,176,184,217,221,234,244],"rare":[7],"and":[8,19,34,59,100,121,129,135,159,183,240],"highly":[9],"aggressive":[10],"malignancy.":[11],"Conventional":[12],"chemotherapeutic":[13,67,151],"agents":[14],"have":[15],"shown":[16],"limited":[17],"utility":[18],"are":[20],"largely":[21],"ineffective":[22],"in":[23,87,220,227],"treating":[24,249],"children":[25,250],"with":[26,77,108,131,197,211,223,251],"advanced":[27],"ACC.":[28],"The":[29,92,139,154],"lack":[30],"of":[31,37,44,52,62,106,110,124,149,162,186,200],"cell":[32],"lines":[33],"animal":[35],"models":[36],"pediatric":[38,55,237],"ACC":[39,56,80,225,238],"has":[40],"hampered":[41],"the":[42,50,53,60,101,111,125,132,145,157,163,167,198],"development":[43],"new":[45],"therapies.":[46],"Here":[47],"we":[48],"report":[49],"establishment":[51],"first":[54],"xenograft":[57,86,126,155,168,239],"model":[58],"characterization":[61],"its":[63],"sensitivity":[64],"to":[65,143,205],"selected":[66,150],"agents.":[68,152],"EXPERIMENTAL":[69],"DESIGN:":[70],"A":[71],"tumor":[72,103,134,208],"from":[73],"an":[74],"11-year-old":[75],"boy":[76],"previously":[78],"untreated":[79],"was":[81,142,203],"established":[82,233],"as":[83,216,243],"subcutaneous":[85],"immunocompromised":[88],"CB17":[89],"scid(-/-)":[90],"mice.":[91],"patient":[93],"harbored":[94],"germline":[96],"TP53":[97,113],"G245C":[98],"mutation,":[99],"primary":[102,133,164],"showed":[104,172],"loss":[105],"heterozygosity":[107],"retention":[109],"mutated":[112],"allele.":[114],"Histopathology,":[115],"DNA":[116],"fingerprinting,":[117],"gene":[118],"expression":[119],"profiling,":[120],"biochemical":[122],"analyses":[123],"were":[127],"conducted":[128],"compared":[130],"normal":[136],"adrenal":[137],"cortex.":[138],"second":[140],"endpoint":[141],"assess":[144],"preliminary":[146],"antitumor":[147,178,195],"activity":[148],"RESULTS:":[153],"maintained":[156],"histopathologic":[158],"molecular":[160],"features":[161],"tumor.":[165],"Screening":[166],"for":[169,248],"drug":[170],"responsiveness":[171],"that":[173],"cisplatin":[174],"had":[175,191],"potent":[177],"effect.":[179],"However,":[180],"etoposide,":[181],"doxorubicin,":[182],"panel":[185],"other":[187],"common":[188],"cancer":[189],"drugs":[190],"little":[192],"or":[193],"no":[194],"activity,":[196],"exception":[199],"topotecan,":[201],"which":[202],"found":[204],"significantly":[206],"inhibit":[207],"growth.":[209],"Consistent":[210],"these":[212],"preclinical":[213],"findings,":[214],"topotecan":[215,242],"single":[218],"agent":[219,247],"child":[222],"relapsed":[224],"resulted":[226],"disease":[228],"stabilization.":[229],"CONCLUSION:":[230],"Our":[231],"study":[232],"novel":[235],"TP53-associated":[236],"identified":[241],"potentially":[245],"effective":[246],"this":[252],"disease.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":3}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2025-10-10T00:00:00"}